Latest Shareholder Value News

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

Agrimin Limited has initiated a strategic review of its flagship Mackay Potash Project following prolonged approvals and market challenges, while spotlighting its valuable stakes in WA1 Resources and an upcoming Tali Resources IPO.

Red Sky Energy has partnered with Condor Energy and associates to fund the drilling of the KN2 well at Killanoola, targeting a promising new reservoir zone identified by advanced seismic data. This move aims to boost production and accelerate cash flow from the South Australian oil project.

Mayfield Childcare Limited reports a significant operational and financial turnaround in Q2 FY25 under new CEO Daniel Stone, with improved earnings and cost efficiencies despite ongoing sector pressures.

Select Harvests Limited reported a robust half-year FY2025 profit, driven by a 37.6% jump in almond prices and strategic debt refinancing. Despite a slightly reduced crop volume, the company’s outlook remains positive amid strong global demand.

Copper Search Limited has announced a non-renounceable entitlement offer to raise approximately $504,364, issuing new shares at $0.017 each with attaching options exercisable at $0.034 until mid-2027. The capital raising aims to support exploration drilling and business development across its Australian mineral projects.

HITIQ has secured a three-year deal with AFL Barwon to promote its PROTEQT smart mouthguard across regional Victoria, enhancing concussion management in community sports.

Ovanti Limited updates shareholders on ongoing CEO recruitment for its US BNPL division and delays in selling its 21% stake in IDSB, highlighting strategic flexibility amid uncertain timelines.

ALS Limited has successfully completed a $350 million institutional placement, issuing 21 million new shares to fund key laboratory upgrades and maintain financial flexibility. The company also launched a $40 million share purchase plan to further support its growth ambitions.

Eagers Automotive reported a record-breaking 2024 with $11.2 billion in revenue and maintained its dividend, while securing a pivotal retail agreement with BYD Australia and unveiling a new community initiative.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.